Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients - Wikidata - awgldk - TriplyDB

Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients

Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients

http://www.wikidata.org/entity/Q35553386

about

Infectious Complications after Umbilical Cord-Blood Transplantation from Unrelated Donors From patient centered risk factors to comprehensive prognostic models: a suggested framework for outcome prediction in umbilical cord blood transplantation.Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.Pulmonary manifestations of the pre-engraftment syndrome after umbilical cord blood transplantation.Bacterial foodborne infections after hematopoietic cell transplantation A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant.Engineered dendritic cells from cord blood and adult blood accelerate effector T cell immune reconstitution against HCMV Human herpesvirus 6B reactivation and delirium are frequent and associated events after cord blood transplantation Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation Practices Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation.High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo.Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications.National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulin.Cytomegalovirus pneumonia in hematopoietic stem cell recipients.Risk factors of CMV infection in patients after umbilical cord blood transplantation: a multicenter study in China.CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML.Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells.Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality.Risk for CMV reactivation in children undergoing allogeneic hematopoietic stem cell transplantation.Cytomegalovirus infection in seropositive unrelated cord blood recipients: a study of 349 Korean patients.Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a developing country: lower rate of acute GVHD, increased risk of cytomegalovirus reactivation.Management of cytomegalovirus infection in haemopoietic stem cell transplantation.Immune reconstitution after combined haploidentical and umbilical cord blood transplant.High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality.

P2860

Q28066500-D1BC5DD2-74B9-43B3-906E-ED8108211FE0 Q33766984-1B309549-60C1-4D9A-85EE-59161CC68152 Q33897804-21BA3699-B9B8-411F-8C63-15CA4B2E300A Q33944909-0BA4840C-C86E-4C94-A42D-AF0FCB2243E7 Q34325320-C8E2DDDC-26B1-4F89-9CE6-1DBB799AEDEF Q35213027-E538EB27-C401-4E4C-BA14-730906A46243 Q35514288-B39E92E1-518B-4F40-BD2A-B7D7FC2670D2 Q35665033-A025E59C-958E-4861-B150-62DE775E7721 Q35801310-2EADE67D-141F-44BA-9A3E-6902C75CBD66 Q35975542-82FAEFFE-9EE4-4007-AD09-9A465ED07E5C Q36164920-73EB0493-1233-44DD-BADC-A37DDF051FF6 Q36306393-9B4E6738-AC9C-4C77-A340-3EB1D2CAB750 Q36622322-333DF32D-531A-46D4-AA3F-A5BF85E0F11A Q36702752-41D3A23A-F222-440F-958B-05445883CF8F Q36743361-31C72C06-B07F-43F5-9377-37A25DC93455 Q36746512-52AE1D7F-83F6-4CAE-BC71-9C598171D4B7 Q36766324-DAC8C2B7-2AFC-44D6-B653-01ADE3F09DAC Q36923436-A07BB215-1E51-4A45-9955-D6B304E7BAAB Q37179131-26D05903-6469-4948-8543-9734D344EB92 Q37413631-07F3CD2B-545C-4F3F-B542-49BB636C6872 Q37611172-0EE29580-D74F-4686-BA6C-F3F32D60A6D9 Q37721514-C279AFAE-B02F-4C54-A148-D6F0F78637DE Q38747929-817F28D3-750E-4FB4-A092-AD3500562111 Q38848582-C67E3E0C-7196-4B62-8225-DE7A998621B7 Q38956462-4E53A3DD-B47E-4D93-908F-CF9E440B5B6E Q41513396-2ED77BBA-DE8F-41B1-9AD8-6D2DD7E4C916 Q41651915-DB6E2068-751F-4C6A-A4B1-751BF05CF7E8 Q42030698-0B620522-B9AD-4B55-9667-AC392BC2CDD4 Q44714539-594EDE90-DC68-4E08-8A3F-D9158BBDA40B Q45142789-DABF657F-8C4A-4FB5-8967-177B44DF81D9 Q47572113-A89999D2-663B-4E00-B34F-CF61FB5C22E2

P2860

Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients

http://www.wikidata.org/entity/Q35553386

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Intensive strategy to prevent ...... rd blood transplant recipients

@ast

Intensive strategy to prevent ...... rd blood transplant recipients

@en

type

label

Intensive strategy to prevent ...... rd blood transplant recipients

@ast

Intensive strategy to prevent ...... rd blood transplant recipients

@en

prefLabel

Intensive strategy to prevent ...... rd blood transplant recipients

@ast

Intensive strategy to prevent ...... rd blood transplant recipients

@en

P1433

Q35553386-368946C1-ACAA-49A9-900E-55157E20A28B

P1476

Q35553386-84CF63CC-20CB-4373-9275-0382311CAB63

P2093

Q35553386-0EB92C62-85D9-490E-BDA0-B7FF631AD059

Q35553386-0FFBF4BB-2D1B-4E93-B8B2-24779D1E98C5

Q35553386-1D678CB7-3882-416C-8CB0-D8FC0320F354

Q35553386-2AC170B4-8F35-4887-8E58-C914F492279C

Q35553386-32DF3694-46B4-4E2C-81AA-C1E08819933E

Q35553386-338BB6CA-295E-4F82-A599-28519CE710C6

Q35553386-AAFC647B-D990-4BE5-B7D2-6DF9580B1BA8

Q35553386-E6E29B82-BDB0-4876-82F4-F6016AB65AE3

P2860

Q35553386-01131D2C-4BEF-4189-B268-5B46E39EF078

Q35553386-0351131B-5D9D-4C0E-8DE3-F3E1969BCBBD

Q35553386-18CCD80F-E03E-4149-9C66-87D1CC703BDB

Q35553386-1B497E75-2810-491F-B113-9D78012855A2

Q35553386-2028ACEC-9805-46B9-813A-391778A85995

Q35553386-295F05BD-DB0C-489B-8185-BBA0E5BB3F36

Q35553386-32A298EF-DAF2-4068-AC32-1AB344509ACC

Q35553386-4148AAC5-6212-43F9-AD94-2B6CB470EE7A

Q35553386-463D306E-3C87-4840-A9F9-2731D3DDE8CE

Q35553386-4C8465F9-9486-4BD9-AFA8-4B08043058C6

P304

Q35553386-5A34326B-A8A5-403E-9F36-FFEC333FD41E

P31

Q35553386-44A29EAC-FDA7-4D3F-8255-335A1CD1DE63

P356

Q35553386-6F67A10D-421A-4951-ADD4-3765BF1112D4

P407

Q35553386-D6988568-AB63-48C6-A0E3-5378C9F9E583

P433

Q35553386-9D1B7DC9-593B-45A1-BD92-BE4B1422F46B

P478

Q35553386-F7826908-8FA4-49D9-B983-6540B00ABDF4

P50

Q35553386-EAB2D153-D868-4082-898D-2DF6BCFA43CE

P577

Q35553386-B470BB8A-413A-4854-9791-E96BD0C6D0DA

P5875

Q35553386-3B803871-B496-4979-80C9-92679147C518

P698

Q35553386-5707E422-58C8-41B6-B713-030B0231D6FC

P932

Q35553386-B7FD73CC-E70E-4569-8DF8-51C8A6F13B5D

P356

BLOOD-2011-06-361618

P1433

P1476

Intensive strategy to prevent ...... rd blood transplant recipients

@en

P2093

Colleen Delaney

http://www.w3.org/2001/XMLSchema#string

Filippo Milano

http://www.w3.org/2001/XMLSchema#string

Hu Xie

http://www.w3.org/2001/XMLSchema#string

Ivy Riffkin

http://www.w3.org/2001/XMLSchema#string

Jonathan A Gutman

http://www.w3.org/2001/XMLSchema#string

Michael J Boeckh

http://www.w3.org/2001/XMLSchema#string

Victor Chow

http://www.w3.org/2001/XMLSchema#string

Wendy M Leisenring

http://www.w3.org/2001/XMLSchema#string

P2860

The dynamics of human cytomegalovirus replication in vivo

Definitions of cytomegalovirus infection and disease in transplant recipients

Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation.

Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infection.

Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation.

Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma

Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.

Reduced mortality after allogeneic hematopoietic-cell transplantation.

Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity.

Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin

P304

5689-5696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2011-06-361618

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Steven A Pergam

P577

2011-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51661434

http://www.w3.org/2001/XMLSchema#string

P698

21937692

http://www.w3.org/2001/XMLSchema#string

P932

3217367

http://www.w3.org/2001/XMLSchema#string